A new technique for atrial fibrillation treatment succeeded in pulsed bowel resection...Less time and fewer side effects than before
Dec 25, 2024
A new medical technology that minimizes side effects in the treatment of atrial fibrillation has been successfully introduced.
Information Young, a professor of cardiology at Severance Hospital, successfully completed the PFA procedure on the 19th for Kwon (53, male) who was diagnosed with atrial fibrillation.
Kwon, who was diagnosed with atrial fibrillation in early 2003, showed persistent symptoms of arrhythmia such as palpitations and frustration despite medication and needed surgical treatment. The PFA procedure, which began just after 8 a.m. on the 19th, ended in less than an hour without any side effects. After Kwon's procedure was completed, four additional patients with atrial fibrillation underwent PFA procedures.
Atrial fibrillation, in which the heart beats irregularly due to structural problems of the heart, is the most common arrhythmia, showing symptoms of stuffy, dizzy, and shortness of breath. Blood flow is irregular, resulting in blood clots (blood cakes), which can cause strokes. The prevalence rate was 1.5% of the total population in 2015, an increase of about twice from 0.7% in 2006. In particular, it occurs in about 10% of people aged 60 or older, and it is expected to be more than 3.5% in 2030 as the population ages.
Atrial fibrillation is treated with medication, electrode catheter resection, and surgery. Double electrode catheter resection is divided into high-frequency electrode catheter resection and cooling resection. In the case of high-frequency electrode catheterization, it is a method of resecting tissue that occurs atrial fibrillation by applying heat with high frequency. Cooling balloon resection removes tissue with refrigeration heat energy.
In both methods, heat energy can be transferred to surrounding tissues other than myocardial tissues, such as esophagus or diaphragm nerves, which can damage tissues. The procedure time can also be more than two hours, putting a burden on the patient.
Pulse Field Ablation (PFA) is a new medical technology that minimizes damage to surrounding tissues and drastically reduces procedure time. It was approved by the U.S. FDA earlier this year and is actively using it to treat atrial fibrillation in the United States, Japan, and Europe. As the procedure has already been performed on more than 120,000 people, its safety has been recognized.
PFA uses pulse field energy rather than heat energy to create microscopic perforation in the heart, preserving surrounding tissue and killing only the target myocardial cells. Each tissue in the heart has a different electric field strength.
Pulse field energy uses a targeting method that removes only the target tissue with a specific electric field strength. Therefore, the procedure time can be shortened by more than 20-40% compared to the existing method, reducing patient burden and significantly reducing side effects such as damage to esophagus and diaphragm nerve.
Professor Information Young said, `PFA has been introduced to Korea as a cutting-edge technology that has been confirmed to be safe and effective in treating atrial fibrillation, allowing patients to receive treatment more safely.'
Information Young, a professor of cardiology at Severance Hospital, successfully completed the PFA procedure on the 19th for Kwon (53, male) who was diagnosed with atrial fibrillation.
Kwon, who was diagnosed with atrial fibrillation in early 2003, showed persistent symptoms of arrhythmia such as palpitations and frustration despite medication and needed surgical treatment. The PFA procedure, which began just after 8 a.m. on the 19th, ended in less than an hour without any side effects. After Kwon's procedure was completed, four additional patients with atrial fibrillation underwent PFA procedures.
Atrial fibrillation, in which the heart beats irregularly due to structural problems of the heart, is the most common arrhythmia, showing symptoms of stuffy, dizzy, and shortness of breath. Blood flow is irregular, resulting in blood clots (blood cakes), which can cause strokes. The prevalence rate was 1.5% of the total population in 2015, an increase of about twice from 0.7% in 2006. In particular, it occurs in about 10% of people aged 60 or older, and it is expected to be more than 3.5% in 2030 as the population ages.
Atrial fibrillation is treated with medication, electrode catheter resection, and surgery. Double electrode catheter resection is divided into high-frequency electrode catheter resection and cooling resection. In the case of high-frequency electrode catheterization, it is a method of resecting tissue that occurs atrial fibrillation by applying heat with high frequency. Cooling balloon resection removes tissue with refrigeration heat energy.
In both methods, heat energy can be transferred to surrounding tissues other than myocardial tissues, such as esophagus or diaphragm nerves, which can damage tissues. The procedure time can also be more than two hours, putting a burden on the patient.
Pulse Field Ablation (PFA) is a new medical technology that minimizes damage to surrounding tissues and drastically reduces procedure time. It was approved by the U.S. FDA earlier this year and is actively using it to treat atrial fibrillation in the United States, Japan, and Europe. As the procedure has already been performed on more than 120,000 people, its safety has been recognized.
PFA uses pulse field energy rather than heat energy to create microscopic perforation in the heart, preserving surrounding tissue and killing only the target myocardial cells. Each tissue in the heart has a different electric field strength.
Pulse field energy uses a targeting method that removes only the target tissue with a specific electric field strength. Therefore, the procedure time can be shortened by more than 20-40% compared to the existing method, reducing patient burden and significantly reducing side effects such as damage to esophagus and diaphragm nerve.
Professor Information Young said, `PFA has been introduced to Korea as a cutting-edge technology that has been confirmed to be safe and effective in treating atrial fibrillation, allowing patients to receive treatment more safely.'
|
bellho@sportschosun.com
